C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2013
12/03/2013	US8597950 Two-component RNA virus-derived plant expression system
12/03/2013	US8597942 System for expression of genes in plants
12/03/2013	US8597925 Homogeneously-structured nano-catalyst/enzyme composite electrode, fabricating method and application of the same
12/03/2013	US8597924 γ-butyrobetaine hydroxylase originated from Neurospora crassa
12/03/2013	US8597902 Peptide protection against ultraviolet light toxicity
12/03/2013	US8597896 Methods to identify modulators using TAS2R bitter taste receptor
12/03/2013	US8597712 Soy beverage substantially free of isoflavones and method of production
12/03/2013	US8597659 Tetrameric cytokines with improved biological activity
12/03/2013	US8597658 HIV-1 envelope glycoprotein oligomer and methods of use
12/03/2013	US8597656 Process for the production of immunogenic compositions
12/03/2013	US8597646 Methods and compositons featuring TGF-beta antagonists for the treatment of marfan syndrome and associated disorders
12/03/2013	US8597645 Cancer treatment with endothelin receptor antagonists
12/03/2013	US8597635 Interferon alpha-2B modified by polyethylene glycol and methods of preparation thereof
12/03/2013	US8597634 Interferon alpha-2a modified by polyethylene glycol and methods of preparation thereof
12/03/2013	CA2583499C Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof
12/03/2013	CA2566481C Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities
12/03/2013	CA2539457C Nucleic acid and gene derived from novel hcv strain and replicon-replicating cell using said gene
12/03/2013	CA2519227C Nogo receptor binding protein
12/03/2013	CA2504270C Peptide fragments of the harp factor inhibiting angiogenesis
12/03/2013	CA2499837C Human papillomavirus polypeptides and immunogenic compositions
12/03/2013	CA2491607C Plant peptide with antimicrobial activity
12/03/2013	CA2489590C Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/03/2013	CA2449426C Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/03/2013	CA2420355C Novel polypeptide and process for producing the same
12/03/2013	CA2397207C Novel stra6 polypeptides
12/03/2013	CA2326627C Nucleotide sequences for detecting enterohemorrhagic escherichia coli (ehec)
12/03/2013	CA2304796C Hepatitis c receptor protein cd81
12/03/2013	CA2213610C Ingap protein involved in pancreatic islet neogenesis
11/2013
11/28/2013	WO2013177529A1 Relaxin-like compounds and uses thereof
11/28/2013	WO2013177440A2 Ordered flagellin array as an immunostimulant
11/28/2013	WO2013177428A1 Methods for increasing muscle contractility
11/28/2013	WO2013177400A1 Arabidopsis nonhost resistance gene(s) and use thereof to engineer disease resistant plants
11/28/2013	WO2013177398A2 Non-natural consensus albumin binding domains
11/28/2013	WO2013177294A1 Reagents and methods for identifying anti-hiv compounds
11/28/2013	WO2013177283A2 Disulfide stabilized foldon polypeptides
11/28/2013	WO2013177247A1 Murine anti-ny-eso-1 t cell receptors
11/28/2013	WO2013177198A1 Ledgf peptides and formulations thereof for treatment of degenerative disorders
11/28/2013	WO2013177153A1 Trichoderma hydrophobin production
11/28/2013	WO2013176623A1 Inhibitors for the treatment of cancer
11/28/2013	WO2013176560A1 An insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes
11/28/2013	WO2013176548A1 New plant resistance gene
11/28/2013	WO2013175815A1 Method for suppressing errors in nucleic acid amplification reaction
11/28/2013	WO2013175321A1 Plants having one or more enhanced yield-related traits and method for making same
11/28/2013	WO2013175258A1 Novel melanoma antigen peptide and uses thereof
11/28/2013	WO2013175256A1 Novel melanoma antigen peptide and uses thereof
11/28/2013	WO2013175237A1 Composition comprising a cd2 ligation agent and a nkg2d ligation agent
11/28/2013	WO2013175207A1 Vaccine
11/28/2013	WO2013175103A1 Method for attenuating a bacterium of the mycobacterium tuberculosis complex for producing a tuberculosis vaccine
11/28/2013	WO2013175015A1 Identification and functional expression of the mitochondrial pyruvate carrier, mpc1
11/28/2013	WO2013174999A1 Virus-like particle based protein-protein interaction
11/28/2013	WO2013174927A1 Production of fucosylated glycoproteins
11/28/2013	WO2013174805A1 Coagulation factor viii with reduced immunogenicity
11/28/2013	WO2013174783A1 Lipocalin muteins with binding-affinity for glypican-3 (gpc-3) and use of lipocalin muteins for target-specific delivery to cells expressing gpc-3
11/28/2013	WO2013174760A1 Optimized aav-vectors for high transduction rates in dendritic cells
11/28/2013	WO2013173910A1 A novel toxin in type a clostridium perfringens
11/28/2013	WO2013173897A2 Gene, ars-r anchorage cassette, ars-r expression- anchorage cassette, recombinant plasmid, bacterial transgenic lineage, use of said gene, use of said lineage in environmental bioremediation processes
11/28/2013	WO2013114363A3 Antimicrobial agents
11/28/2013	WO2009036095A8 Engineered light-harvesting organisms
11/28/2013	WO2002077260A8 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/28/2013	WO2002059349A8 Odorant receptors and uses thereof
11/28/2013	US20130318648 Diagnosis and therapeutic epitope, and transgenic plant
11/28/2013	US20130317217 Affinity adsorbents for fibrinogen
11/28/2013	US20130317172 Method for immobilizing temperature responsive protein a
11/28/2013	US20130316962 Muteins of hNGAL and related proteins with affinity for a given target
11/28/2013	US20130316960 Novel Peptides For Treating and Preventing Immune-Related Disorders, Including Treating And Preventing Infection by Modulating Innate Immunity
11/28/2013	US20130316959 Use of endostatin peptides for the treatment of fibrosis
11/28/2013	US20130316958 Highly potent peptides to control cancer and neurodegenerative diseases
11/28/2013	US20130316957 Smoothened polypeptides and methods of use
11/28/2013	US20130316956 Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
11/28/2013	US20130316952 Non-Natural Consensus Albumin Binding Domains
11/28/2013	US20130316951 Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same
11/28/2013	US20130316950 Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases
11/28/2013	US20130316946 Extended recombinant polypeptide-modified c-peptide
11/28/2013	US20130316944 Engineered cxcl12 alpha locked dimer polypeptide
11/28/2013	US20130316941 Glucagon analogues
11/28/2013	US20130316929 Peptide library
11/28/2013	US20130316448 Peptides and related molecules that modulate nerve growth factor activity
11/28/2013	US20130316404 Covalently linked interleukin-10
11/28/2013	US20130316400 High yield transient expression in mammalian cells using unique pairing of high density growth and transfection medium and expression enhancers
11/28/2013	US20130316376 Spider silk fusion protein structures for binding to an organic target
11/28/2013	US20130316354 Mammalian cytokine; related reagents
11/28/2013	US20130316057 Isolated polypeptides and polynucleotides encoding same for generating plants with increased cuticlar water permeability
11/28/2013	US20130315984 Anti-trypanosomal peptides and uses thereof
11/28/2013	US20130315949 Molecular Antigen Array
11/28/2013	US20130315947 Vaccination of Animals to Elicit a Protective Immune Response Against Tick Infestations and Tick-Borne Pathogen Transmission
11/28/2013	US20130315944 Infectious genomic dna clone and serological profile of torque teno sus virus 1 and 2
11/28/2013	US20130315943 Truncated l1 protein of human papillomavirus type 58
11/28/2013	US20130315942 WDRPUH Epitope Peptides and Vaccines Containing the Same
11/28/2013	US20130315935 Oligomeric receptor ligand pair member complexes
11/28/2013	US20130315929 Vaccine antigens that direct immunity to conserved epitopes
11/28/2013	US20130315920 Cross Protective Epitopes of Aspergillus Fumigatus and Candida Albicans
11/28/2013	US20130315916 Respiratory syncytial virus vaccine
11/28/2013	US20130315915 Methods and compositions for diagnosing and treating diseases
11/28/2013	US20130315905 B7-H5, A Costimulatory Polypeptide
11/28/2013	US20130315889 Cartilage oligomeric matrix protein (comp)-growth factor complexes and uses thereof
11/28/2013	US20130315872 Neuron-specific retrograde transport vector
11/28/2013	US20130315860 Methods and compositions based on diphtheria toxin-interleukin-3 conjugates
11/28/2013	US20130315856 Conjugates for the treatment of mesothelioma
11/28/2013	US20130315833 Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (cmr1)
11/28/2013	US20130312868 Method and Device for Fast Dissolution of Solid Protein Composition

1 ... 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 ... 2916